Itzhak Goldberg - Jun 24, 2021 Form 4 Insider Report for Angion Biomedica Corp. (ELTX)

Role
Executive Chairman and Chief Scientific Officer
Signature
/s/ Jennifer J. Rhodes, as attorney-in fact for Itzhak Goldberg
Stock symbol
ELTX
Transactions as of
Jun 24, 2021
Transactions value $
-$1,282,361
Form type
4
Date filed
11/17/2021, 05:02 PM
Next filing
Dec 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELTX Common Stock Tax liability -$653K -47.4K -2.29% $13.78 2.02M Jun 24, 2021 Direct F1
transaction ELTX Common Stock Sale -$465K -112K -5.52% $4.17 1.91M Nov 15, 2021 Direct F2, F3
transaction ELTX Common Stock Sale -$164K -38.5K -2.02% $4.26 1.87M Nov 16, 2021 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were withheld to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs").
F2 The shares reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2021 by the Reporting Person
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.48 inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.21 to $4.38 inclusive.

Remarks:

Executive Chairman and Chief Scientific Officer